血管闭合装置市场：依产品类型、依接取方式、依孔径、依最终用户、按地区

血管闭合装置市场规模预计在 2025 年达到 15.336 亿美元，预计到 2032 年将达到 23.212 亿美元，2025 年至 2032 年的复合年增长率为 6.1%。

血管闭合装置有助于在心血管手术（例如血管造影术和血管成形术）后封闭动脉穿刺口。它们透过机械或生物方式促进自然凝血，从而帮助止血。随着全球介入性心臟病学和放射学的发展，血管闭合装置的全球使用量也不断增加。与手动压迫方法相比，血管闭合装置可提高病患舒适度、缩短住院时间并降低併发症发生率，已成为血管通路管理的重要组成部分。

市场动态

由于人口变化和技术进步等多种因素的共同作用，全球血管闭合装置市场正在经历显着增长。这种增长的主要原因是老年人口的增加，由于生理衰老，老年人更容易患心血管疾病。随着老年人口的增加，心血管疾病的发生率也在上升，导致对诊断和治疗程序后有效的血管闭合装置的需求增加。同时，整个医疗保健产业明显转向微创手术 (MIS)。与传统开放性手术相比，MIS 手术可降低感染风险、缩短住院时间并加速患者復原。血管闭合装置在这些手术中起着关键作用，可快速止血、减少活动时间并提高患者的舒适度。

器械技术的进步也至关重要，它使器械的功效更高，并降低了术后併发症的风险。设计和材料的改进使产品能够提供更好的密封性，并适应各种解剖结构和穿刺尺寸。然而，这些先进器械的高成本可能会成为其广泛应用的障碍。某些医疗保健系统缺乏报销机制，进一步加剧了这个问题，使患者难以获得这些技术。现有的止血替代方法，例如手动按压，通常会导致更长的恢復时间并增加併发症的风险。

该市场蕴含着巨大的机会，尤其是在新兴经济体，这些经济体的医疗保健投资和医疗基础建设正在不断加强。新型器械的持续开发潜力巨大，例如由生物分解性材料製成的器械，这些器械常用于经导管主动脉瓣置换术(TAVR) 等复杂手术。总体而言，血管闭合器械的优势，例如技术进步和对微创手术 (MIS) 的需求不断增长，可能会继续推动市场成长，儘管成本和报销等挑战仍然存在。

例如，2021 年 1 月，专注于提供创新医疗解决方案以促进更好患者治疗效果的医疗技术公司 Haemonetics Corporation 签署了最终协议，收购私人公司的血管闭合系统製造商 Cardiva Medical, Inc.。

研究的主要特点

• 本报告对全球血管闭合装置市场进行了详细分析，并以 2024 年为基准年，提供了预测期 2025-2032 的市场规模（百万美元）和年复合成长率（CAGR%）。
• 它揭示了各个领域的潜在商机，并解释了该市场的有吸引力的投资提案矩阵。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
• 它根据公司亮点、产品系列、关键亮点、绩效和策略等参数，介绍了全球血管闭合装置市场的主要企业概况。
• 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
• 全球血管闭合装置市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
• 相关人员将透过全球血管闭合装置市场分析中使用的各种策略矩阵更轻鬆地做出决策。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要
• 一致的机会图（COM）

第三章市场动态、法规与趋势分析

• 市场动态
• 人口老化加剧
• 血管成形术的激增
• 心血管疾病盛行率不断上升
• 微创手术需求不断成长
• 影响分析
• 监管情景
• 产品发布/核准
• PEST分析
• 波特分析
• 併购场景

4. 全球血管闭合装置市场（依产品类型），2020 年至 2032 年

• 介绍
• 被动血管闭合装置
• 主动血管闭合装置
• 外部闭合装置

5. 全球血管闭合装置市场（依访问量划分），2020 年至 2032 年

• 介绍
• 股骨
• 半径

6. 2020-2032 年全球血管闭合装置市场（依孔径）

• 介绍
• 小孔
• 远射

7. 全球血管闭合装置市场（依最终用户划分），2020 年至 2032 年

• 介绍
• 医院
• 门诊手术中心
• 其他的

8. 全球血管闭合装置市场（按地区划分），2020-2032 年

• 介绍
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 东南亚国协
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
• 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
• 非洲
  • 南非
  • 北非
  • 中部非洲

第九章 竞争态势

• Abbott
• Cardiva Medical Inc.
• Terumo Corporation
• Johnson & Johnson Services Inc.
• B. Braun SE
• BIoTronik SE & Co. KG
• MicroPort Scientific Corporation
• ConforMIS, Inc.
• Medtronic
• Transluminal Technologies LLC
• Cardinal Health
• Teleflex Incorporated
• Vasorum Ltd.
• Tricol Biomedical
• Merit Medical Systems, Inc.
• Stryker

第 10 章 章节

• 调查方法
• 关于出版商

Vascular Closure Device Market is estimated to be valued at USD 1,533.6 Mn in 2025 and is expected to reach USD 2,321.2 Mn by 2032, growing at a compound annual growth rate (CAGR) of 6.1% from 2025 to 2032.

Vascular closure devices help seal arterial punctures after a cardiovascular procedure such as angiography or angioplasty. They help stop bleeding at the puncture site by accelerating natural clotting through mechanical or biological means. The global usage of vascular closure devices has been increasing with growth in interventional cardiology and radiology procedures worldwide. Improved patient comfort, reduced hospital stay times, and lower complication rates compared to manual compression methods have made vascular closure devices an integral part of vascular access site management.

Market Dynamics

The global vascular closure device market is growing substantially, propelled by a confluence of factors ranging from demographic shifts to technological progress. A significant contributor to this growth is the rising geriatric population which is more susceptible to cardiovascular diseases due to physiological aging. As the elderly population grows, so does the incidence of cardiovascular conditions, thereby increasing the demand for effective vascular closure devices following diagnostic and therapeutic procedures. Simultaneously, a notable shift towards minimally invasive surgeries (MIS) across the healthcare sector. MIS procedures reduce the risk of infection, shorten hospital stays, and speed up patient recovery times compared to traditional open surgeries. Vascular closure devices play a key role in these procedures by providing rapid hemostasis, reducing time to ambulation, and enhancing patient comfort.

Advancements in device technology have also been pivotal, leading to devices that offer greater efficacy and a reduced risk of post-procedure complications. Enhanced designs and materials have yielded products with improved sealing capabilities and compatibility with various anatomies and puncture sizes. On the other side of the spectrum, the high costs associated with these advanced devices can act as a barrier to their widespread adoption. The lack of reimbursement in certain healthcare systems further exacerbates this issue, making it challenging for patients to access these technologies. While existing alternatives for achieving hemostasis, such as manual compression, exist, they often come with longer recovery times and elevated risks of complications, thereby providing an opening for the adoption of advanced vascular closure devices.

The market is ripe with opportunities, especially within emerging economies that are currently witnessing increased healthcare investments and enhancements to their healthcare infrastructure. The significant potential in the ongoing development of novel devices, including those made from biodegradable materials, commonly used in complex procedures like transcatheter aortic valve replacement (TAVR).Overall, while challenges like cost and reimbursement issues persist, the benefits of vascular closure devices, including the advancements in technology and rising demands for MIS, are likely to continue to drive market growth.

For instance, in January 2021, Haemonetics Corporation, a medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, entered into a definitive agreement to acquire privately-held Cardiva Medical, Inc., a manufacturer of vascular closure systems.

Key features of the study

• This report provides in-depth analysis of the global vascular closure device market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global vascular closure device market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Abbott, Cardiva Medical Inc., Terumo Corporation, Johnson & Johnson Services Inc., B. Braun SE, Biotronik SE & Co. KG, MicroPort Scientific Corporation, ConforMIS, Inc., Medtronic, Transluminal Technologies LLC, Cardinal Health, Teleflex Incorporated, Vasorum Ltd., Tricol Biomedical, Merit Medical Systems, Inc., Stryker
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global vascular closure device market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global vascular closure device market.

Market Segmentation

• By Product Type
  • Passive Vascular Closure Devices
  • Active Vascular Closure Devices
  • External Hemostatic Devices
• By Access
  • Femoral
  • Radial
• By Hole Size
  • Small Hole
  • Large Hole
• By End User
  • Hospitals
  • Ambulatory Surgery Centers
  • Others
• By Region
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Top companies in Global Vascular Closure Device Market
  • Abbott
  • Cardiva Medical Inc.
  • Terumo Corporation
  • Johnson & Johnson Services Inc.
  • B. Braun SE
  • Biotronik SE & Co. KG
  • MicroPort Scientific Corporation
  • ConforMIS, Inc.
  • Medtronic
  • Transluminal Technologies LLC
  • Cardinal Health
  • Teleflex Incorporated
  • Vasorum Ltd.
  • Tricol Biomedical
  • Merit Medical Systems, Inc.
  • Stryker

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Vascular Closure Device Market, By Product Type
  • Vascular Closure Device Market, By Access
  • Vascular Closure Device Market, By Hole Size
  • Vascular Closure Device Market, By End User
  • Vascular Closure Device Market, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Driver
• Rising geriatric population
• The proliferation of angioplasty procedures
• The increasing prevalence of cardiovascular diseases incidence
• Increasing demand for minimally invasive surgeries
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Vascular Closure Device Market, By Product Type, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Passive Vascular Closure Devices
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Mn)
• Active Vascular Closure Devices
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Mn)
• External Hemostatic Devices
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Mn)

5. Global Vascular Closure Device Market, By Access, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Femoral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Mn)
• Radial
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Mn)

6. Global Vascular Closure Device Market, By Hole Size, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Small Hole
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Mn)
• Large Hole
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Mn)

7. Global Vascular Closure Device Market, By End User, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Mn)
• Ambulatory Surgery Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Mn)

8. Global Vascular Closure Device Market, By Region, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, By Country, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Country 2021 -2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Access, 2020-2032,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Hole Size, 2020-2032,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Mn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Access, 2020-2032,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Hole Size, 2020-2032,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Mn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Access, 2020-2032,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Hole Size, 2020-2032,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Access, 2020-2032,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Hole Size, 2020-2032,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Mn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Access, 2020-2032,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Hole Size, 2020-2032,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Access, 2020-2032,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Hole Size, 2020-2032,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(USD Mn)
    • South Africa
    • North Africa
    • Central Africa

9. Competitive Landscape

• Abbott
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Cardiva Medical Inc.
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Terumo Corporation
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Johnson & Johnson Services Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• B. Braun SE
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Biotronik SE & Co. KG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• MicroPort Scientific Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• ConforMIS, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Medtronic
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Transluminal Technologies LLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Cardinal Health
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Teleflex Incorporated
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Vasorum Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Tricol Biomedical
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Merit Medical Systems, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Stryker
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

10. Section

• Research Methodology
• About us